SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

202021,191 citationsJournal Articlebronze Open Access

Authors

Good health and well-being

Published in: Cell

Volume 181, Issue 2, pp. 271-280.e8

Field-Weighted Citation Impact: 472.81